Home > > > > Report Detail

North America Pain Management Drugs Market Forecast 2019-2027

Publisher Name :
Date: 14-Jan-2019
No. of pages: 90

KEY FINDINGS

The North American pain management market is evolving at a CAGR of 3.62% during the forecasting years of 2019-2027. The respective growth can be reasoned to the humongous population of the aging generation in the region and the favorable regulatory conditions prevalent in the market. The United States and Canada are considered in the market study.

MARKETING INSIGHTS

There is a higher consumption rate of pain medication with fewer side-effects. This is a major attributing factor for the North America pain management market. Recent development in the technology for the advancement of abuse-deterrent drugs in the region is positively impacting the North American market. The United States market for pain management drug held the largest market share in 2018 due to favorable healthcare reforms in the country to improve the affordability of such medications.

COMPETITIVE INSIGHTS

GlaxoSmithKline, Purdue Pharma L.P., Acura Pharmaceuticals, Inc., Novartis, Daiichi Sankyo, Inc., Egalet Corp., Eli Lilly and Company, Insys Therapeutics, Inc., Abbott Laboratories, Hikma Pharmaceuticals PLC, Johnson & Johnson, Lupin Ltd., Pfizer, Inc., Merck & Co., Inc. and Cipher Pharmaceuticals Inc. are the eminent market players in the pain management market in the North America region.

North America Pain Management Drugs Market Forecast 2019-2027

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. OPIOIDS MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF DRUG CLASS
3.2.2. CANCER PAIN INDICATION IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. GROWTH IN THE INCIDENCE AND PREVALENCE OF CHRONIC DISEASES
4.2.2. THE RISE IN AWARENESS REGARDING THE SIDE-EFFECTS OF PAIN MEDICATION
4.2.3. RISE IN GERIATRIC POPULATION
4.3. MARKET RESTRAINTS
4.3.1. ACCESSIBILITY OF ALTERNATIVE THERAPIES
4.3.2. INCREASE IN DRUG MISTREATMENT
4.4. MARKET OPPORTUNITIES
4.4.1. TECHNOLOGICAL ADVANCEMENT
4.4.2. GROWTH POTENTIAL IN UNTAPPED ECONOMIES
4.5. MARKET CHALLENGES
4.5.1. PATENT EXPIRATION
5. MARKET BY DRUG CLASS
5.1. NSAIDS
5.2. ANESTHETICS
5.3. ANTICONVULSANTS
5.4. ANTI-MIGRAINE AGENTS
5.5. ANTIDEPRESSANTS
5.6. OPIOIDS
5.7. NON-NARCOTIC ANALGESICS
6. MARKET BY INDICATION
6.1. ARTHRITIC PAIN
6.2. NEUROPATHIC PAIN
6.3. CANCER PAIN
6.4. CHRONIC BACK PAIN
6.5. POST-OPERATIVE PAIN
6.6. MIGRAINE
6.7. FIBROMYALGIA
7. KEY ANALYTICS
7.1. PORTER'S FIVE FORCE MODEL
7.1.1. THREAT OF NEW ENTRANTS
7.1.2. THREAT OF SUBSTITUTE
7.1.3. BARGAINING POWER OF SUPPLIERS
7.1.4. BARGAINING POWER OF BUYERS
7.1.5. THREAT OF COMPETITIVE RIVALRY
7.2. REGULATORY FRAMEWORK
7.3. OPPORTUNITY MATRIX
7.4. VALUE CHAIN ANALYSIS
7.5. VENDOR LANDSCAPE
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. THE UNITED STATES
8.1.2. CANADA
9. COMPETITIVE LANDSCAPE
9.1. MARKET SHARE ANALYSIS
9.2. COMPANY PROFILES
9.2.1. ABBOTT LABORATORIES
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCT PORTFOLIO
9.2.1.3. SCOT ANALYSIS
9.2.1.4. STRATEGIC INITIATIVES
9.2.2. ACURA PHARMACEUTICALS, INC.
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCT PORTFOLIO
9.2.2.3. STRATEGIC INITIATIVES
9.2.3. CIPHER PHARMACEUTICALS INC.
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCT PORTFOLIO
9.2.3.3. STRATEGIC INITIATIVES
9.2.4. DAIICHI SANKYO, INC.
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCT PORTFOLIO
9.2.4.3. STRATEGIC INITIATIVES
9.2.5. EGALET CORP.
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCT PORTFOLIO
9.2.5.3. STRATEGIC INITIATIVES
9.2.6. ELI LILLY AND COMPANY
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCT PORTFOLIO
9.2.6.3. SCOT ANALYSIS
9.2.6.4. STRATEGIC INITIATIVES
9.2.7. GLAXOSMITHKLINE
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCT PORTFOLIO
9.2.7.3. SCOT ANALYSIS
9.2.7.4. STRATEGIC INITIATIVES
9.2.8. HIKMA PHARMACEUTICALS PLC
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCT PORTFOLIO
9.2.8.3. STRATEGIC INITIATIVES
9.2.9. JOHNSON & JOHNSON
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCT PORTFOLIO
9.2.9.3. SCOT ANALYSIS
9.2.9.4. STRATEGIC INITIATIVES
9.2.10. LUPIN LTD.
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCT PORTFOLIO
9.2.10.3. STRATEGIC INITIATIVES
9.2.11. PFIZER, INC.
9.2.11.1. COMPANY PROFILES
9.2.11.2. PRODUCT PORTFOLIO
9.2.11.3. SCOT ANALYSIS
9.2.11.4. STRATEGIC INITIATIVES
9.2.12. PURDUE PHARMA L.P.
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCT PORTFOLIO
9.2.12.3. STRATEGIC INITIATIVES
9.2.13. MERCK & CO., INC.
9.2.13.1. COMPANY PROFILES
9.2.13.2. PRODUCT PORTFOLIO
9.2.13.3. SCOT ANALYSIS
9.2.13.4. STRATEGIC INITIATIVES
9.2.14. NOVARTIS
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCT PORTFOLIO
9.2.14.3. SCOT ANALYSIS
9.2.14.4. STRATEGIC INITIATIVES
9.2.15. INSYS THERAPEUTICS, INC.
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCT PORTFOLIO
9.2.15.3. STRATEGIC INITIATIVES
TABLE LIST
TABLE 1 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA NSAIDS MARKET 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA ANESTHETICS MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA ANTICONVULSANTS MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA ANTI-MIGRAINE AGENTS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA ANTIDEPRESSANTS MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA OPIOIDS MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA NON-NARCOTIC ANALGESICS MARKET 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA ARTHRITIC PAIN MARKET 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA NEUROPATHIC PAIN MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA CANCER PAIN MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA CHRONIC BACK PAIN MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA POST-OPERATIVE PAIN MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA MIGRAINE MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA FIBROMYALGIA MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 20 THE UNITED STATES PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)
TABLE 21 THE UNITED STATES PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)
TABLE 22 CANADA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)
TABLE 23 CANADA PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)


FIGURES LIST
FIGURE 1 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET SHARE BY DRUG CLASS 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY NSAIDS 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ANESTHETICS 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ANTICONVULSANTS 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ANTI-MIGRAINE AGENTS 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ANTIDEPRESSANTS 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY OPIOIDS 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY NON-NARCOTIC ANALGESICS 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET SHARE BY INDICATION 2018 & 2027 (%)
FIGURE 11 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY ARTHRITIC PAIN 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY NEUROPATHIC PAIN 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY CANCER PAIN 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY CHRONIC BACK PAIN 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY POST-OPERATIVE PAIN 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY MIGRAINE 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY FIBROMYALGIA 2019-2027 ($ MILLION)
FIGURE 18 PORTER'S FIVE FORCE MODEL
FIGURE 19 NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 20 THE UNITED STATES PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 21 CANADA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)
FIGURE 22 PAIN MANAGEMENT MARKET SHARE ANALYSIS 2017 (%)
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs